Purpose
to evaluate and advance a novel technological platform to increase the potency and breadth of monoclonal antibodies against SARS-CoV-2 and other infectious disease agents
Grantee
Division
Global Health
Date
OCTOBER 2020
Region served
GLOBAL
Committed amount
$7,323,359
Grant topic
Discovery and Translational Sciences,
HIV,
Malaria
Duration (months)
53
Grantee location
Toronto, ON, Canada
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.